Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
ZYBT

Market Cap: $73.46M

ZL

Zhengye Biotechnology Holding Limited

ZYBT

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin8.30%

EBITDA Margin-51.72%

EBIT Margin-77.04%

Pre-tax Margin-75.85%

Net Profit Margin-89.05%

Earnings Yield-14.49%

Valuation Multiples

Price / Book1.97

Price / Sales6.15

Price / Earnings-6.97

PEG-0.07

Forward PEG-0.07

EV / Sales6.45

EV / EBITDA-12.48

EV / Operating Cash Flow12.85

EV / Free Cash Flow13.22

Price / Free Cash Flow12.59

Price / Operating Cash Flow12.24

Cash Flow & Capital

Free Cash Flow / Share$0.82

Operating Cash Flow / Share$0.85

Free Cash Flow Yield7.94%

Capex / Revenue1.40%

Capex / Operating Cash Flow2.79%

Capex / Depreciation0.06

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.14

Quick Ratio0.82

Cash Ratio0.42

Debt / Assets0.17

Debt / Capital0.23

Debt / Equity0.30

Long-Term Debt / Capital0.03

Debt / Market Cap15.17%

Net Debt / EBITDA-0.60

Solvency Ratio-0.39

Financial Leverage1.75

Efficiency & Working Capital

Asset Turnover0.18

Fixed Asset Turnover0.34

Inventory Turnover1.87

Receivables Turnover4.33

Payables Turnover1.67

Days Sales Outstanding84.28

Days Inventory Outstanding194.74

Days Payables Outstanding218.83

Operating Cycle279.02

Cash Conversion Cycle60.2

Working Capital Turnover4.72

Returns & Quality

Return on Equity-26.78%

Return on Assets-16.33%

Return on Invested Capital-16.15%

ROCE-19.52%

Return on Tangible Assets-18.67%

Operating Return on Assets-14.13%

Income Quality-0.56

Tax Burden1.17

Interest Burden0.98

Balance Sheet & Intrinsic Metrics

Enterprise Value$516.72M

Invested Capital$308.98M

Working Capital$16.94M

Tangible Asset Value$251.96M

Net Current Asset Value$7.66M

Graham Net-Net-$0.94

Book Value / Share$6.47

Tangible Book Value / Share$5.32

Cash / Share$1.09